Czechia, Jan. 6 -- Czechia based Merck Sharp & Dohme s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Medicinal products for the cardiovascular system - LP for the treatment of pulmonary arterial hypertension (PAH) XIV - Sotatercept I. The value of the contract is worth 5796508805 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....